文献速递预防保健、筛查与疫苗

确保癌症筛查的知情决策

Ensuring Informed Decision-Making for Cancer Screening.
PubMed 文献 · J Am Board Fam Med · 2021-01-01

该文讨论家庭医生在癌症筛查决策中的角色,指出筛查获益并非直截了当,当前实践既要求与患者共享决策,又强调鼓励参与筛查项目。作者认为应更开放地说明筛查的局限性,帮助患者做出符合其价值观和优先事项的知情决定。

要点

  • 癌症筛查的获益并不简单直接。
  • 共享决策已成为家庭医生的预期实践。
  • 应更开放地说明筛查局限性以支持知情决策。

核心结论

  • 癌症筛查的成功不应仅以参与人数衡量。
  • 家庭医学应优先改善癌症结局,但不应削弱对知情决策的承诺。
  • 应更开放地说明癌症筛查的局限性,帮助患者做出符合其价值观的决定。

主要发现

  • 癌症筛查历史表明筛查的论证并不简单直接。
  • 当代实践中与患者共享决策已成为家庭医生的预期。
  • 同时越来越强调鼓励患者参与筛查项目以改善癌症结局。
  • 癌症筛查的成功常以参与人数来评判。

临床怎么用

  • 家庭医生应与患者共享决策,帮助其做出符合价值观和优先事项的知情选择。
  • 在鼓励参与筛查的同时,应开放说明筛查的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The history of cancer screening has demonstrated that the case for cancer screening is not straightforward. In contemporary practice, sharing decision-making with patients has become expected of family physicians. At the same time, increasing emphasis has been placed on encouraging patients to participate in screening programs to improve cancer outcomes. The success of cancer screening is often judged by the number of those who participate. Improving cancer outcomes should be a priority for family medicine, but the importance of this goal should not undermine doctors' commitment to helping patients make informed decisions that are consistent with their values and priorities. If we are serious about empowering patients, we need to be more open about the limitations of cancer screening, to help patients make up their minds.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Bradley SH, Thompson MJ, Nicholson BD, et al. Ensuring Informed Decision-Making for Cancer Screening. J Am Board Fam Med. 2021. PMID: 33833015. doi:10.3122/jabfm.2021.02.200353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。